Exact Mass: 452.3141

5alpha-Cyprinol

C27H48O5 (452.3502)

5b-Cholestane-3a,7a,12a,25,26-pentol

C27H48O5 (452.3502)

DG(18:1(11Z)/18:1(11Z)/0:0) is a diglyceride, or a diacylglycerol (DAG). It is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Diacylglycerols can have many different combinations of fatty acids attached at both the C-1 and C-2 positions. DG(18:1(11Z)/18:1(11Z)/0:0), in particular, consists of two chains of vaccenic acid at the C-1 and C-2 positions. The vaccenic acid moieties are derived from butter fat and animal fat. Mono- and diacylglycerols are common food additives used to blend together certain ingredients, such as oil and water, which would not otherwise blend well. Dacylglycerols are often found in bakery products, beverages, ice cream, chewing gum, shortening, whipped toppings, margarine, and confections. 5b-Cholestane-3a,7a,12a,25,26-pentol is a bile alcohol. Bile alcohols have been found to be present as minor components in the bile and urine in healthy subjects. Bile alcohols are end products for cholesterol elimination as well as major biliary constituents; in mammals, cholesterol is metabolized by additional enzymes that ultimately transform it to bile acids. Bile alcohols are preferentially excreted as glucuronides into the urine, which constitute about 10\\% of total bile acids. Large amounts of bile alcohols have been found to be excreted into the bile and urine in patients with cerebrotendinous xanthomatosis (CTX), a rare inherited lipid storage disease. (PMID: 11718684).

5beta-cholestan-3alpha,7alpha,12alpha,24(S),27-pentol

C27H48O5 (452.3502)

5beta-cholestan-3alpha,7alpha,12alpha,24(S),27-pentol, also known as 5β-cholestan-3α,7α,12α,24(S),27-pentol, is classified as a pentahydroxy bile acids, alcohol or a Pentahydroxy bile acids, alcohol derivative. Pentahydroxy bile acids, alcohols are bile acids, alcohols or derivatives bearing five hydroxyl groups. 5beta-cholestan-3alpha,7alpha,12alpha,24(S),27-pentol is considered to be practically insoluble (in water) and relatively neutral

Tyromycic acid

C30H44O3 (452.329)

Tyromycic acid is found in mushrooms. Tyromycic acid is a constituent of Ganoderma lucidum (reishi) Constituent of Ganoderma lucidum (reishi). Tyromycic acid is found in mushrooms.

5b-Cholestane-3a,7a,12a,24,25-pentol

C27H48O5 (452.3502)

5b-Cholestane-3a,7a,12a,24,25-pentol has been found excreted in the urine from a patient with sitosterolemia as glycine- and taurine-conjugated bile acids (PMID 7896564) [HMDB] 5b-Cholestane-3a,7a,12a,24,25-pentol has been found excreted in the urine from a patient with sitosterolemia as glycine- and taurine-conjugated bile acids (PMID 7896564).

3-Oxo-12,18-ursadien-28-oic acid

C30H44O3 (452.329)

3-Oxo-12,18-ursadien-28-oic acid is found in pomes. 3-Oxo-12,18-ursadien-28-oic acid is a constituent Pyrus communis (pear). Constituent Pyrus communis (pear). 3-Oxo-18-dehydroursolic acid is found in pomes.

5b-Cholestane-3a,7a,12a,23S,25-pentol

C27H48O5 (452.3502)

5b-Cholestane-3a,7a,12a,23S,25-pentol is a bile alcohol found in the urine of patients with cerebrotendinous xanthomatosis. (PMID 3700361) [HMDB] 5b-Cholestane-3a,7a,12a,23S,25-pentol is a bile alcohol found in the urine of patients with cerebrotendinous xanthomatosis. (PMID 3700361).

5b-Cholestane-3a,7a,12a,23R,25-pentol

C27H48O5 (452.3502)

5b-Cholestane-3a,7a,12a,23R,25-pentol is a bile alcohol present in the urine of patients with cerebrotendinous xanthomatosis, but not in feces. A possible explanation for the urinary cholestanepentols is that the major serum bile alcohol, 5b-cholestane-3a,7a,12a,25-tetrol, might be hydroxylated at C-23 to form (23)-5b-cholestane-3a,7a,12a,23,25-pentols in the kidneys, an hypothesis supported by the fact that in our patient (23R)-5b-cholestane-3a,7a,12a,23,25-pentol was detected only in urine but were virtually absent in bile. (PMID 3700361). Widespread in plant oils and as glycerides in seed oilsand is also present in apple, apricot, banana, morello cherry, citrus fruits, cheese, butter, white wine, Japanese whiskey, peated malt, wort and scallops. It is used as a defoamer, lubricant and citrus fruit coating. Salts (Na, K, Mg, Ca, Al) used as binders, emulsifiers and anticaking agents in food manuf. Decanoic acid is found in many foods, some of which are radish (variety), meatball, phyllo dough, and american shad.

5a-Cholestane-3a,7a,12a,23,25-pentol

C27H48O5 (452.3502)

5a-Cholestane-3a,7a,12a,23,25-pentol is a bile acid found in the urine of patients with cerebrotendinous xanthomatosis. (PMID 1805458) [HMDB] 5a-Cholestane-3a,7a,12a,23,25-pentol is a bile acid found in the urine of patients with cerebrotendinous xanthomatosis. (PMID 1805458).

Cholestane-3,7,12,24,25-pentol

C27H48O5 (452.3502)

Cholestane-3,7,12,24,25-pentol is the major bile alcohol identified in urine from healthy humans, both in children and adults. Bile alcohols have been found to be present as minor components in the bile and urine in healthy subjects. Bile alcohols are end products for cholesterol elimination as well as major biliary constituents; in mammals, cholesterol is metabolized by additional enzymes that ultimately transform it to bile acids. Bile alcohols are preferentially excreted as glucuronides into the urine, which constitute about 10\\% of total bile acids. The excretion of glucuronidated bile alcohols in urine is suggested to reflect an alternative metabolism of intermediates in the normal biosynthesis of bile acids. Patients with the rare inherited sterol storage disease, cerebrotendinous xanthomatosis, accumulation bile alcohols in bile and feces.(PMID: 6726087, 6548247, 11718684) [HMDB] Cholestane-3,7,12,24,25-pentol is the major bile alcohol identified in urine from healthy humans, both in children and adults. Bile alcohols have been found to be present as minor components in the bile and urine in healthy subjects. Bile alcohols are end products for cholesterol elimination as well as major biliary constituents; in mammals, cholesterol is metabolized by additional enzymes that ultimately transform it to bile acids. Bile alcohols are preferentially excreted as glucuronides into the urine, which constitute about 10\\% of total bile acids. The excretion of glucuronidated bile alcohols in urine is suggested to reflect an alternative metabolism of intermediates in the normal biosynthesis of bile acids. Patients with the rare inherited sterol storage disease, cerebrotendinous xanthomatosis, accumulation bile alcohols in bile and feces.(PMID: 6726087, 6548247, 11718684).

1-nonadecanoyl-glycero-3-phosphate

C22H45O7P (452.2903)

1-nonadecanoyl-glycero-3-phosphate is classified as a member of the 1-acylglycerol-3-phosphates. 1-acylglycerol-3-phosphates are lysophosphatidic acids where the glycerol is esterified with a fatty acid at O-1 position. 1-nonadecanoyl-glycero-3-phosphate is a glycerophosphate lipid molecule

5beta-cholestane-3alpha,7alpha,12alpha,23,25-pentol

C27H48O5 (452.3502)

5beta-cholestane-3alpha,7alpha,12alpha,23,25-pentol, also known as 5β-cholestane-3α,7α,12α,23,25-pentol, is classified as a pentahydroxy bile acids, alcohol or a Pentahydroxy bile acids, alcohol derivative. Pentahydroxy bile acids, alcohols are bile acids, alcohols or derivatives bearing five hydroxyl groups. 5beta-cholestane-3alpha,7alpha,12alpha,23,25-pentol is considered to be practically insoluble (in water) and relatively neutral. 5beta-cholestane-3alpha,7alpha,12alpha,23,25-pentol is a bile acid lipid molecule

LysoPA(19:0/0:0)

C22H45O7P (452.2903)

LysoPA(19:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(19:0/0:0), in particular, consists of one chain of nonadecylic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

LysoPA(i-19:0/0:0)

C22H45O7P (452.2903)

LysoPA(i-19:0/0:0) is a lysophosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. Lysophosphatidic acids can have different combinations of fatty acids of varying lengths and saturation attached at the C-1 (sn-1) or C-2 (sn-2) position. Fatty acids containing 16 and 18 carbons are the most common. LysoPA(i-19:0/0:0), in particular, consists of one chain of isononadecanoic acid at the C-1 position. Lysophosphatidic acid is the simplest possible glycerophospholipid. It is the biosynthetic precursor of phosphatidic acid. Although it is present at very low levels only in animal tissues, it is extremely important biologically, influencing many biochemical processes.

24,24-Difluoro-1alpha,25-dihydroxyvitamin D3

C27H42F2O3 (452.3102)

5alpha-Cyprinol

C27H48O5 (452.3502)

Parenabol

C30H44O3 (452.329)

D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea

C31H36N2O (452.2827)

(8S,9S,10R,13R,14S,17R)-5,6-Dihydroperoxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol

C27H48O5 (452.3502)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C25H40O7 (452.2774)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

C25H40O7 (452.2774)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

C25H40O7 (452.2774)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C25H40O7 (452.2774)

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

C25H40O7 (452.2774)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0)

C25H40O7 (452.2774)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0)

C25H40O7 (452.2774)

DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(2:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0)

C25H40O7 (452.2774)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/2:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R))

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0)

C25H40O7 (452.2774)

DG(20:4(8Z,11Z,14Z,17Z)-2OH(5S,6R)/0:0/2:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

Strychnine

C21H22N2O2.1/2H2SO4 (452.292)

Tyromycic acid E

C30H44O3 (452.329)

Melliferone

C30H44O3 (452.329)

Chabrolobenzoquinone F

C29H40O4 (452.2926)

Kulactone

C30H44O3 (452.329)

16,21-Epoxylanosta-7,24-diene-3,21-dione is a natural product found in Melia with data available.

Supinenolone D

C30H44O3 (452.329)

3-Oxo-11,13(18)-oleandien-28-oic acid

C30H44O3 (452.329)

Lucialdehyde B

C30H44O3 (452.329)

A tetracyclic triterpenoid that is lanosta-8,24-dien-26-al substituted by oxo groups at positions 3 and 7. Isolated from Ganoderma lucidum and Ganoderma pfeifferi, it exhibits antiviral and cytotoxic activities.

Antiostatin B3

C26H36N4O3 (452.2787)

Stellettin J

C30H44O3 (452.329)

Antiostatin B4

C26H36N4O3 (452.2787)

Briarellin P

C25H40O7 (452.2774)

Tyromycic acid

C30H44O3 (452.329)

3-Oxo-7,9(11)-multifloradien-29-oic acid

C30H44O3 (452.329)

15-Hydroxy-3-oxolanosta-7,9(11),24-trien-26-al

C30H44O3 (452.329)

kadsulactone

C30H44O3 (452.329)

Parenabol

C30H44O3 (452.329)

3-Oxoursan (28-13)Olide

C30H44O3 (452.329)

(20R,24S)-5alpha-cholesta-3beta,6alpha,8,15alpha,24-pentaol|(24S)-5alpha-cholestane-3beta,6alpha,8,15alpha,24-pentol

C27H48O5 (452.3502)

Wilforlide B

C30H44O3 (452.329)

Wilforlide B is a natural product found in Tripterygium regelii and Tripterygium wilfordii with data available.

Laserpitinol

C25H40O7 (452.2774)

zizyberenalic acid

C30H44O3 (452.329)

methyl-13S-hydroxy-14R,15-diacetoxy-1(10)-ent-halimen-18-oate

C25H40O7 (452.2774)

2alpha,3beta-dihydroxy-28-norurs-12,17,19(20),21(22)-tetraen-23-oic acid|2alpha,3beta-dihydroxy-28-norursa-12,17,19(20),21-tetraen-23-oic acid

C29H40O4 (452.2926)

(1S,4R,5R)-3-hydroxymethyl-4,5-dimethoxycyclohex-2-enyl (3E)-octadec-3-enoate

C27H48O5 (452.3502)

3-Oxo-ursadien-(12.19)-saeure-(28)|Sanguisorbigenon|sanguisorbigenone|Tomentosonsaeure

C30H44O3 (452.329)

SCHEMBL370562

C26H44O6 (452.3138)

18-dihydrocinnamoyloxy-labda-7,13E-dien-15-oic acid

C29H40O4 (452.2926)

ganoderic aldehyde TR

C30H44O3 (452.329)

cholestan-1beta,3beta,5alpha,6beta,11alpha-pentol

C27H48O5 (452.3502)

19-(p-hydroxyhydrocinnamoyloxy)-ent-kauran-17-al|19--ent-kauran-17-al

C29H40O4 (452.2926)

(17R,20R)-cycloart-24-en-3,16,23-trione|(9beta)-9,19-cyclolanost-24-ene-3,16,23-trione|5alpha-cycloart-24-ene-3,16,23-trione|gummiferartane-6

C30H44O3 (452.329)

1,8,15,22-Tetraaza-2,7,16,21-cyclooctacosanetetrone

C24H44N4O4 (452.3362)

Neokadsuranic acid A

C30H44O3 (452.329)

Z,E,Z-cupaniopsin C

C30H44O3 (452.329)

C27H48O5

C27H48O5 (452.3502)

flindissone lactone|Flindissonlacton

C30H44O3 (452.329)

(3beta, 5alpha, 6beta, 15alpha, 25S)-Cholestane-3, 5, 6, 15, 25-pentol

C27H48O5 (452.3502)

Ananosic acid C

C30H44O3 (452.329)

grindelic acid 15-O-arabinoside

C25H40O7 (452.2774)

MS000063860

C30H44O3 (452.329)

(22Z,24E)-3-oxocycloart-22,24-dien-26-oic acid

C30H44O3 (452.329)

14,15-Di-Ac,17-Me ester-13,14,15-Trihydroxy-7-labden-17-oic acid

C25H40O7 (452.2774)

Ecdysteron

C25H40O7 (452.2774)

Trihomononactic acid cyclic dimer

C26H44O6 (452.3138)

(20xi)-3-oxolanosta-7,9(11),24-trien-21-oic acid|3-oxolanosta-7,9(11),24-trien-21-oic acid|dehydrotrametenonic acid

C30H44O3 (452.329)

shimalactone B

C29H40O4 (452.2926)

C29H40O4

C29H40O4 (452.2926)

(2,3-dihydro-3-methylenebenzo[b]oxepin-7-yl)methyl oleate

C30H44O3 (452.329)

thurberogenone

C30H44O3 (452.329)

SCHEMBL17867100

C24H44N4O4 (452.3362)

Withanolide B

C29H40O4 (452.2926)

3-Oxo-1,20(29)-lupadien-26-oic acid

C30H44O3 (452.329)

Neokadsuranic acid B

C30H44O3 (452.329)

Ingenamine C acetate

C29H44N2O2 (452.3403)

1,8,15,22-Tetraazacyclooctacosane-2,9,16,23-tetrone

C24H44N4O4 (452.3362)

C25H40O7

C25H40O7 (452.2774)

pistacigerrimone E

C30H44O3 (452.329)

13-O-alpha-rhamnopyranosyl-(+)-3beta-hydroxymanool

C26H44O6 (452.3138)

cucurbita-5,24-diene-3,7,23-trione

C30H44O3 (452.329)

Chiograsterol B

C27H48O5 (452.3502)

(4S,5S,7R,10S)-Eudesm-11-en-4-ol 2-O-((2S) 2-methylbutyryl)-beta-D-fucopyranoside|(4S,5S,7R,10S)-Eudesm-11-en-4-ol 2-O-<(2S) 2-methylbutyryl>-beta-D-fucopyranoside

C26H44O6 (452.3138)

27-Hydroxy-3-oxo-witha-1,4,24-trienolide

C29H40O4 (452.2926)

pistacigerrimone C

C30H44O3 (452.329)

(1beta)-25(9-8)-Abeo-3-oxo-4(23)-friedelen-24,1-olide

C30H44O3 (452.329)

Excelsine

C29H40O4 (452.2926)

(7S,11S,12S)-1-methoxycystoketal

C29H40O4 (452.2926)

pseudoferic acid A

C29H40O4 (452.2926)

kadpolysperin E

C30H44O3 (452.329)

carinatin F

C30H44O3 (452.329)

dothideomycetone B

C25H40O7 (452.2774)

5,6-acetonylgrayanotoxin-I

C25H40O7 (452.2774)

(2S,3S,6R,7R,10R,11R,14S)-zonaquinone acetate

C29H40O4 (452.2926)

O-3-isovaleroyl alpha-bisabolol beta-D-fucopyranoside

C26H44O6 (452.3138)

(2Z,6R)-2-methyl-6-[(12beta)-4,4,10,12,14-pentamethyl-3-oxogona-8,13(17)-dien-17-yl]hept-2-enoic acid|kadindutic acid

C30H44O3 (452.329)

18-methylmalonyl-7alpha-hydroxy-methyltrineracetal

C25H40O7 (452.2774)

3alpha,7alpha,12alpha,23-Tetrahydroxy-cholansaeure-ethylester

C26H44O6 (452.3138)

(23R)-3-oxo-5alpha,9beta-lanosta-7,24-dien-26,23-olide

C30H44O3 (452.329)

Papyriogenin J

C30H44O3 (452.329)

amphidinolide T2

C26H44O6 (452.3138)

Arapaimol A

C27H48O5 (452.3502)

norselic acid A

C29H40O4 (452.2926)

8|A-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnamate

C29H40O4 (452.2926)

26-hydroxy-5alpha-lanosta-7,9(11),24-triene-3,22-dione

C30H44O3 (452.329)

DTXSID20855115

C26H44O6 (452.3138)

Natalic acid

C29H40O4 (452.2926)

C26H44O6

C26H44O6 (452.3138)

Ochraceolide C

C30H44O3 (452.329)

pistacigerrimone A

C30H44O3 (452.329)

lettowinone|methyl [3-(3,7-dimethylocta.2,6-dienyl)-6-methyl-5-(3-methylbut-2-enyl)-1,4-dioxo-1,5,8,8a-tetrahydro-4H-naphthalen-4a-yl]acetate

C29H40O4 (452.2926)

Ochraceolide A

C30H44O3 (452.329)

6alpha,8alpha,23,14,15-erythro-pentahydroxy-labd-13(21),17-dien-16,19-olide|6alpha,8alpha,23,14,15-threo-pentahydroxy-labd-13(21),17-dien-16,19-olide

C25H40O7 (452.2774)

3-keto-lup-12-ene-21->28-olide

C30H44O3 (452.329)

2.3-dihydroxy-24-nor-friedelatetraen-(1.3.5(10).7)-oic acid-(29)|2.3-Dihydroxy-24-nor-friedelatetraen-(1.3.5(10).7)-saeure-(29)|Dihydrocelastrol

C29H40O4 (452.2926)

3,23-dioxotirucalla-7,24-dien-21-al

C30H44O3 (452.329)

13S-labda-8(17),14-diene-13-(cis-hydroxycinnamoxy)-19-ol

C29H40O4 (452.2926)

C30H44O3

C30H44O3 (452.329)

6beta,7beta,11beta,14beta,15beta-pentahydroxy-20-isoamoxy-7alpha,20-epoxy-ent-kaur-16-ene|hebeirubescensin F

C25H40O7 (452.2774)

Ganoderic aldehyde A

C30H44O3 (452.329)

3-oxo-D:C-friedo-olena-7,9(11)-dien-29-oic acid|3-oxo-D:C-friedooleana-7,9(11)-dien-29-oic acid

C30H44O3 (452.329)

17-hydroxy-19-(p-hydroxyhydrocinnamoyloxy)-iso-kaurene|17-hydroxy-19--iso-kaurene

C29H40O4 (452.2926)

Agelenotoxin 452

C23H44N6O3 (452.3475)

Benzamide, N-(20-amino-4,8,12,17-tetraazaeicos-1-yl)-2,5-dihydroxy-

C23H44N6O3 (452.3475)

4,14-di-2,15-dihydro puliscabrin

C30H44O3 (452.329)

Tomentin

C25H40O7 (452.2774)

Dresigenin B

C26H44O6 (452.3138)

Triptohypol C

C29H40O4 (452.2926)

Triptohypol C is a pentacyclic triterpenoid with formula C29H40O4, originally isolated from the root bark of Tripterygium regelii. It has a role as a plant metabolite and an apoptosis inducer. It is a pentacyclic triterpenoid, a monocarboxylic acid and a member of benzenediols. Dihydrocelastrol is a natural product found in Tripterygium hypoglaucum and Tripterygium wilfordii with data available. A pentacyclic triterpenoid with formula C29H40O4, originally isolated from the root bark of Tripterygium regelii. Triptohypol C, a Tripterin (HY-13067) derivative, is a potent Nur77-targeting anti-inflammatory agent with an Kd value of 0.87 μM. Triptohypol C inhibits inflammatory response by promoting the interactions of Nur77 with TRAF2 and p62/SQSTM1[1].

Glabralide C

C29H40O4 (452.2926)

Boldenone_Undecylenate

C30H44O3 (452.329)

C30H44O3_(22E,24E)-3-Oxo-9,19-cyclolanosta-22,24-dien-26-oic acid

C30H44O3 (452.329)

18,19-dihydrousambarine

C30H36N4 (452.294)

Dihydrocelastrol

C29H40O4 (452.2926)

3-Oxoursan (28-13)Olide_major

C30H44O3 (452.329)

(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-17-((R)-7-hydroxy-6-(hydroxymethyl)heptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R,5S)-5,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3S,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((R)-7-hydroxy-6-(hydroxymethyl)heptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3R,7R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3R,5S,7R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3R,5R,7R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

4,4-difluoro-1α,25-dihydroxyvitamin D3 / 4,4-difluoro-1α,25-dihydroxycholecalciferol

C27H42F2O3 (452.3102)

(5Z,7E)-(1S,3S)-4,4-difluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

C27H42F2O3 (452.3102)

23,23-difluoro-1α,25-dihydroxyvitamin D3 / 23,23-difluoro-1α,25-dihydroxycholecalciferol

C27H42F2O3 (452.3102)

24,24-difluoro-1α,25-dihydroxyvitamin D3 / 24,24-difluoro-1α,25-dihydroxycholecalciferol

C27H42F2O3 (452.3102)

(5Z,7E,17E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),17(20)-cholestatetraen-22-yne-1,3,25-triol

C30H44O3 (452.329)

(5Z,7E,17Z)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),17(20)-cholestatetraen-22-yne-1,3,25-triol

C30H44O3 (452.329)

(5Z,7E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),20-cholestatetraen-22-yne-1,3,25-triol

C30H44O3 (452.329)

(5Z,7E,22E,24E,24bE)-(1S,3R)-24a,24b,24c-trihomo-9,10-seco-5,7,10(19),22,24,24b-cholestahexaene-1,3,25-triol

C30H44O3 (452.329)

VD 2728

C30H44O3 (452.329)

VD 2736

C30H44O3 (452.329)

5β-Cholestane-3α,6β,7α,25,26-pentol

C27H48O5 (452.3502)

5β-Cholestane-2β,3α,7α,12α,26-pentol

C27H48O5 (452.3502)

5α-Cholestane-3β,7α,12α,26,27-pentol

C27H48O5 (452.3502)

5α-Cholestane-3β,7α,12α,25,26-pentol

C27H48O5 (452.3502)

5α-Cholestane-3α,7α,12α,25,26-pentol

C27H48O5 (452.3502)

5β-Cholestane-3α,7α,12α,25,26-pentol

C27H48O5 (452.3502)

5α-Cholestane-3α,7α,12α,24,26-pentol

C27H48O5 (452.3502)

5β-Cholestane-3α,7α,12α,24,26-pentol

C27H48O5 (452.3502)

5β-Cholestane-3α,6β,7β,25,26-pentol

C27H48O5 (452.3502)

5β-Cholestane-3α,6α,7β,25,26-pentol

C27H48O5 (452.3502)

5β-Cholestane-3α,7α,12α,22,25-pentol

C27H48O5 (452.3502)

5β-Cholestane-3α,7α,12α,23,25-pentol

C27H48O5 (452.3502)

5β-Cholestane-3α,7α,12α,24,25-pentol

C27H48O5 (452.3502)

5β-Cholestane-3α,7α,12α,26,27-pentol

C27H48O5 (452.3502)

5α-Cholestane-3α,7α,12α,23,25-pentol

C27H48O5 (452.3502)

5β-Cholestane-3α,7α,12α,22,26-pentol

C27H48O5 (452.3502)

5β-Cholestane-3α,7α,12α,23,26-pentol

C27H48O5 (452.3502)

5b-Cholestane-3a,7a,12a,24,25-pentol

C27H48O5 (452.3502)

Cholestane-3,7,12,23,25-pentol

C27H48O5 (452.3502)

Cholestane-3alpha,7alpha,12alpha,24R,25-pentol

C27H48O5 (452.3502)

Cholestane-3,7,12,24,25-pentol

C27H48O5 (452.3502)

PA(19:0/0:0)

C22H45O7P (452.2903)

PA(O-20:0/0:0)

C23H49O6P (452.3267)

alpha-Trichechol

C27H48O5 (452.3502)

5beta-Cholestane-2beta,3alpha,7alpha,12alpha,26-pentol

C27H48O5 (452.3502)

Latimerol

C27H48O5 (452.3502)

5alpha-Cholestane-3beta,7alpha,12alpha,25,26-pentol

C27H48O5 (452.3502)

Bufol

C27H48O5 (452.3502)

5beta-Cholestane-3alpha,7alpha,12alpha,25,26-pentol

C27H48O5 (452.3502)

Chimaerol

C27H48O5 (452.3502)

5beta-Cholestane-3alpha,7alpha,12alpha,24,26-pentol

C27H48O5 (452.3502)

Cyprinol

C27H48O5 (452.3502)

beta-Trichechol

C27H48O5 (452.3502)

omega-Trichechol

C27H48O5 (452.3502)

5beta-Cholestane-3alpha,7alpha,12alpha,22,25-pentol

C27H48O5 (452.3502)

5beta-Cholestane-3alpha,7alpha,12alpha,23,25-pentol

C27H48O5 (452.3502)

5beta-Cholestane-3alpha,7alpha,12alpha,24,25-pentol

C27H48O5 (452.3502)

5beta-Cholestane-3alpha,7alpha,12alpha,26,27-pentol

C27H48O5 (452.3502)

5alpha-Cholestane-3alpha,7alpha,12alpha,23,25-pentol

C27H48O5 (452.3502)

5beta-Cholestane-3alpha,7alpha,12alpha,22,26-pentol

C27H48O5 (452.3502)

5beta-Cholestane-3alpha,7alpha,12alpha,23,26-pentol

C27H48O5 (452.3502)

3-Oxo-12,18-ursadien-28-oic acid

C30H44O3 (452.329)

Sarcoehrendin I

C25H40O7 (452.2774)

LPA 19:0

C22H45O7P (452.2903)

LPA O-20:0

C23H49O6P (452.3267)

ST 27:0;O5

C27H48O5 (452.3502)

Endertiin A

C30H44O3 (452.329)

4,4-difluoro-1alpha,25-dihydroxyvitamin D3

C27H42O3F2 (452.3102)

23,23-difluoro-1alpha,25-dihydroxyvitamin D3

C27H42O3F2 (452.3102)

24,24-difluoro-1alpha,25-dihydroxyvitamin D3

C27H42O3F2 (452.3102)

(17E)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a-homovitamin D3

C30H44O3 (452.329)

(17Z)-1alpha,25-dihydroxy-26,27-dimethyl-17,20,22,22,23,23-hexadehydro-24a-homovitamin D3

C30H44O3 (452.329)

1alpha,25-dihydroxy-26,27-dimethyl-20,21,22,22,23,23-hexadehydro-24a-homovitamin D3

C30H44O3 (452.329)

(22E,24E,24bE)-1alpha,25-dihydroxy-22,23,24,24a,24b,24c-hexadehydro-24a,24b,24c-trihomovitamin D3

C30H44O3 (452.329)

POLY(LAURYL METHACRYLATE-CO-ETHYLENE GLYCOL DIMETHACRYLATE)

C26H44O6 (452.3138)

8α-Hydroxylabda-13(16),14-dien-19-yl p-hydroxycinnaMate

C29H40O4 (452.2926)

N-(2-ethoxyphenyl)-N-(4-isododecylphenyl)oxamide

C28H40N2O3 (452.3039)

Boldenone undecylenate

C30H44O3 (452.329)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C2360 - Anabolic Steroid D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

Pentaerythrityl Tetracaprylate

C23H48O8 (452.3349)

1-Cycloheptyl-1-(9H-fluoren-2-ylmethyl)-3-(2,4,6-trimethylphenyl)urea

C31H36N2O (452.2827)

YM-750 is a potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor (IC50=0.18 μM). ACAT catalyzes the formation of cholesteryl esters from cholesterol and long-chain fatty-acyl-coenzyme A[1][2].

(24S)-5beta-cholestane-3alpha,7alpha,12alpha,24,26-pentol

C27H48O5 (452.3502)

5beta-Cholestane-3alpha,7alpha,12alpha,24,26-pentol with S-configuration at C-24.

Butropium

C28H38NO4+ (452.2801)

C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

Tacrine(8)-4-aminoquinoline

C30H36N4 (452.294)

23,23-difluoro-1alpha,25-dihydroxyvitamin D3/23,23-difluoro-1alpha,25-dihydroxycholecalciferol

C27H42F2O3 (452.3102)

5beta-Cyprinol

C27H48O5 (452.3502)

N-hexadecanoyl-sn-glycero-3-phosphoethanolamine(1-)

C21H43NO7P- (452.2777)

[(2S,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-bis(azaniumyl)-3-[[(2S,3R)-3-azaniumyl-6-(azaniumylmethyl)-3,4-dihydro-2H-pyran-2-yl]oxy]-2-hydroxycyclohexyl]oxy-3,5-dihydroxy-5-methyloxan-4-yl]-methylazanium

C19H42N5O7+5 (452.3084)

(8S,9S,10R,13R,14S,17R)-5,6-Dihydroperoxy-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-ol

C27H48O5 (452.3502)

(5Z)-5-[(2E)-2-[1-(5,5-difluoro-6-hydroxy-6-methylheptan-2-yl)-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol

C27H42F2O3 (452.3102)

DG(2:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0)

C25H40O7 (452.2774)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/2:0/0:0)

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(6Z,8E,10E,14Z)-2OH(5S,12R))

C25H40O7 (452.2774)

DG(20:4(6Z,8E,10E,14Z)-2OH(5S,12R)/0:0/2:0)

C25H40O7 (452.2774)

DG(2:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/0:0)

C25H40O7 (452.2774)

DG(20:4(6E,8Z,11Z,13E)-2OH(5S,15S)/2:0/0:0)

C25H40O7 (452.2774)

DG(2:0/0:0/20:4(6E,8Z,11Z,13E)-2OH(5S,15S))

C25H40O7 (452.2774)

[3-carboxy-2-[(10E,12E,14E)-9-hydroxy-16-oxooctadeca-10,12,14-trienoyl]oxypropyl]-trimethylazanium

C25H42NO6+ (452.3012)

[3-carboxy-2-[(10E,12E,14E)-16-hydroxy-9-oxooctadeca-10,12,14-trienoyl]oxypropyl]-trimethylazanium

C25H42NO6+ (452.3012)

[3-Carboxy-2-[11-(3-methyl-5-propylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium

C26H46NO5+ (452.3376)

[3-Carboxy-2-[10-(3,4-dimethyl-5-propylfuran-2-yl)decanoyloxy]propyl]-trimethylazanium

C26H46NO5+ (452.3376)

[3-Carboxy-2-[11-(5-ethyl-3,4-dimethylfuran-2-yl)undecanoyloxy]propyl]-trimethylazanium

C26H46NO5+ (452.3376)

[3-Carboxy-2-[7-(5-hexyl-3,4-dimethylfuran-2-yl)heptanoyloxy]propyl]-trimethylazanium

C26H46NO5+ (452.3376)

[3-Carboxy-2-[8-(3,4-dimethyl-5-pentylfuran-2-yl)octanoyloxy]propyl]-trimethylazanium

C26H46NO5+ (452.3376)

[2-[9-(5-Butyl-3,4-dimethylfuran-2-yl)nonanoyloxy]-3-carboxypropyl]-trimethylazanium

C26H46NO5+ (452.3376)

[3-Carboxy-2-[9-(3-methyl-5-pentylfuran-2-yl)nonanoyloxy]propyl]-trimethylazanium

C26H46NO5+ (452.3376)

8alpha-Hydroxylabda-13(16),14-dien-19-yl-cis-4-hydroxycinnamate

C29H40O4 (452.2926)

A natural product found in Metasequoia glyptostroboides.

ganoderic acid S

C30H44O3 (452.329)

(2E,4E)-2-methyl-6-(7,7,12,16-tetramethyl-6-oxo-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl)hepta-2,4-dienoic acid

C30H44O3 (452.329)

6alpha-Hydroxy-28-norcastasterone

C27H48O5 (452.3502)

5alpha-cholestan-3beta,6alpha,8beta,15alpha,24S-triol

C27H48O5 (452.3502)

4-(dimethylamino)-N-[[(8R,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,13,14-tetrazabicyclo[10.2.1]pentadeca-12(15),13-dien-9-yl]methyl]-N-methylbutanamide

C22H40N6O4 (452.3111)

4-(dimethylamino)-N-[[(8R,9S)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbutanamide

C22H40N6O4 (452.3111)

4-(dimethylamino)-N-[[(8S,9R)-6-[(2R)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbutanamide

C22H40N6O4 (452.3111)

4-(dimethylamino)-N-[[(8R,9S)-6-[(2S)-1-hydroxypropan-2-yl]-8-methyl-5-oxo-10-oxa-1,6,14,15-tetrazabicyclo[10.3.0]pentadeca-12,14-dien-9-yl]methyl]-N-methylbutanamide

C22H40N6O4 (452.3111)

(3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3R,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R,5S)-5,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3R,5R,7R,8S,9S,10S,12S,13R,14S,17R)-17-((R)-7-hydroxy-6-(hydroxymethyl)heptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3S,5R,7R,8R,9S,10S,12S,13R,14S,17R)-17-((R)-7-hydroxy-6-(hydroxymethyl)heptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-17-((2R)-6,7-dihydroxy-6-methylheptan-2-yl)-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthrene-3,7,12-triol

C27H48O5 (452.3502)

Cholestane-3alpha,7alpha,12alpha,25,26-pentol

C27H48O5 (452.3502)

2-[[(2R)-2-acetyloxy-3-undec-10-enoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium

C21H43NO7P+ (452.2777)

2-[hydroxy-[(2R)-2-hydroxy-3-[(E)-tetradec-1-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C22H47NO6P+ (452.3141)

2-[hydroxy-[(2R)-2-hydroxy-3-[(Z)-tetradec-1-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C22H47NO6P+ (452.3141)

[(2S)-2-hydroxy-3-[(3R,7R,11R)-3,7,11,15-tetramethylhexadecoxy]propyl] dihydrogen phosphate

C23H49O6P (452.3267)

(1-hexanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-octadeca-9,12-dienoate

C27H48O5 (452.3502)

[2-(Heptanoylamino)-3-hydroxynonyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

[2-(Hexanoylamino)-3-hydroxydecyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

[2-(Butanoylamino)-3-hydroxydodecyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

[3-Hydroxy-2-(propanoylamino)tridecyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

(2-Acetamido-3-hydroxytetradecyl) 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

[3-Hydroxy-2-(pentanoylamino)undecyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

(1-hydroxy-3-octanoyloxypropan-2-yl) (9Z,12Z)-hexadeca-9,12-dienoate

C27H48O5 (452.3502)

[3-Hydroxy-2-(octanoylamino)octyl] 2-(trimethylazaniumyl)ethyl phosphate

C21H45N2O6P (452.3015)

(1-hydroxy-3-pentanoyloxypropan-2-yl) (9Z,12Z)-nonadeca-9,12-dienoate

C27H48O5 (452.3502)

(1-butanoyloxy-3-hydroxypropan-2-yl) (11Z,14Z)-icosa-11,14-dienoate

C27H48O5 (452.3502)

(1-heptanoyloxy-3-hydroxypropan-2-yl) (9Z,12Z)-heptadeca-9,12-dienoate

C27H48O5 (452.3502)

(1-hydroxy-3-propanoyloxypropan-2-yl) (11Z,14Z)-henicosa-11,14-dienoate

C27H48O5 (452.3502)

(1-acetyloxy-3-hydroxypropan-2-yl) (13Z,16Z)-docosa-13,16-dienoate

C27H48O5 (452.3502)

2-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxyethyl-trimethylazanium

C21H43NO7P+ (452.2777)

2-[hydroxy-[2-hydroxy-3-[(Z)-tetradec-9-enoxy]propoxy]phosphoryl]oxyethyl-trimethylazanium

C22H47NO6P+ (452.3141)

5b-Cholestane-3a,7a,12a,23R,25-pentol

C27H48O5 (452.3502)

1-nonadecanoyl-glycero-3-phosphate

C22H45O7P (452.2903)

5a-Cholestane-3a,7a,12a,23,25-pentol

C27H48O5 (452.3502)

5b-Cholestane-3a,7a,12a,23S,25-pentol

C27H48O5 (452.3502)

(25S)-5alpha-cholestan-3beta,6beta,15alpha,16beta,26-pentol

C27H48O5 (452.3502)

(5Z,7E,16Z,22E,24E)-(1S,3R)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),22,24-cholestahexaene-1,3,25-triol

C30H44O3 (452.329)

(5Z,7E,16Z,22E,24E)-(1S,3R,20S)-26,27-dimethyl-24a-homo-9,10-seco-5,7,10(19),22,24-cholestahexaene-1,3,25-triol

C30H44O3 (452.329)

lysophosphatidylethanolamine zwitterion 16:0

C21H43NO7P (452.2777)

A lysophosphatidylethanolamine zwitterion in which the remaining acyl group (position not specified) contains 16 carbons and 0 double bonds.

5beta-bufol

C27H48O5 (452.3502)

The 5beta-stereoisomer of bufol.

5alpha-bufol

C27H48O5 (452.3502)

The 5alpha-stereoisomer of bufol.

BisMeLPA(17:0)

C22H45O7P (452.2903)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

DG(24:2)

C27H48O5 (452.3502)

Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

NA-Trp 17:2(9Z,12Z)

C28H40N2O3 (452.3039)

NA-Orn 20:2

C25H44N2O5 (452.325)

FAHFA 10:2/O-19:6

C29H40O4 (452.2926)

FAHFA 10:3/O-19:5

C29H40O4 (452.2926)

FAHFA 11:2/O-18:6

C29H40O4 (452.2926)

FAHFA 11:3/O-18:5

C29H40O4 (452.2926)

FAHFA 12:3/O-17:5

C29H40O4 (452.2926)

FAHFA 12:4/O-17:4

C29H40O4 (452.2926)

FAHFA 13:3/O-16:5

C29H40O4 (452.2926)

FAHFA 13:4/O-16:4

C29H40O4 (452.2926)

FAHFA 14:3/O-15:5

C29H40O4 (452.2926)

FAHFA 14:4/O-15:4

C29H40O4 (452.2926)

FAHFA 15:4/O-14:4

C29H40O4 (452.2926)

FAHFA 15:5/O-14:3

C29H40O4 (452.2926)

FAHFA 16:4/O-13:4

C29H40O4 (452.2926)

FAHFA 16:5/O-13:3

C29H40O4 (452.2926)

FAHFA 17:4/O-12:4

C29H40O4 (452.2926)

FAHFA 17:5/O-12:3

C29H40O4 (452.2926)

FAHFA 18:5/O-11:3

C29H40O4 (452.2926)

FAHFA 18:6/O-11:2

C29H40O4 (452.2926)

FAHFA 19:5/O-10:3

C29H40O4 (452.2926)

FAHFA 19:6/O-10:2

C29H40O4 (452.2926)

FAHFA 20:5/O-9:3

C29H40O4 (452.2926)

FAHFA 20:6/O-9:2

C29H40O4 (452.2926)

FAHFA 21:6/O-8:2

C29H40O4 (452.2926)

FAHFA 21:7/O-8:1

C29H40O4 (452.2926)

FAHFA 29:8;O

C29H40O4 (452.2926)

FAHFA 8:1/O-21:7

C29H40O4 (452.2926)

FAHFA 8:2/O-21:6

C29H40O4 (452.2926)

FAHFA 9:2/O-20:6

C29H40O4 (452.2926)

FAHFA 9:3/O-20:5

C29H40O4 (452.2926)

DG 24:2

C27H48O5 (452.3502)

LPEth 17:0

C22H45O7P (452.2903)

LPM 18:0

C22H45O7P (452.2903)

SM 16:0;O2

C21H45N2O6P (452.3015)

SM 8:0;O2/8:0

C21H45N2O6P (452.3015)

ST 20:0;O;Hex

C26H44O6 (452.3138)

ST 26:1;O;S

C26H44O4S (452.296)

ST 26:1;O6

C26H44O6 (452.3138)

2,5,6,10,10,14,21-heptamethyl-23-oxahexacyclo[19.2.1.0²,¹⁹.0⁵,¹⁸.0⁶,¹⁵.0⁹,¹⁴]tetracos-17-ene-11,22-dione

C30H44O3 (452.329)

2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid

C30H44O3 (452.329)

2,5,8-trihydroxy-4-(3-hydroxypropanoyl)-4,7-dimethyl-3-(undecan-2-yl)-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

C26H44O6 (452.3138)

3-methyl-6-(1-{7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl}ethyl)-5,6-dihydropyran-2-one

C30H44O3 (452.329)

6-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid

C30H44O3 (452.329)

(2e,6r)-6-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enal

C30H44O3 (452.329)

3-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-5-(2-methylprop-1-en-1-yl)oxolan-2-one

C30H44O3 (452.329)

(2s)-2-[(1s,3as,5ar,9ar,9br,11as)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-6-methyl-4-oxohept-5-enal

C30H44O3 (452.329)

(1s,3r,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-15-[(2r)-6-methyl-4-oxohept-5-en-2-yl]pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-6,14-dione

C30H44O3 (452.329)

(2z,5r,7e,11z)-2-[3-(furan-3-yl)propylidene]-8,12,16-trimethyl-5-(prop-1-en-2-yl)heptadeca-7,11,15-trienoic acid

C30H44O3 (452.329)

(3r,3ar,5as,7as,11as,13as,13br)-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,7h,7ah,10h,11h,13h,13bh-cyclopenta[a]chrysene-6,9,12-trione

C30H44O3 (452.329)

(1r,3ar,5ar,5bs,7as,11as,11bs,13ar,13br)-3a,5a,8,8,11a-pentamethyl-9-oxo-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,11bh,12h,13h,13ah,13bh-cyclopenta[a]chrysene-5b-carboxylic acid

C30H44O3 (452.329)

(2e)-5-[(1s,4ar,5r,8ar)-2,5,8a-trimethyl-5-{[(3-phenylpropanoyl)oxy]methyl}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-2-enoic acid

C29H40O4 (452.2926)

(1r,3as,9as,9bs,11as)-1-[(2r,5r)-5-ethyl-5-hydroxy-6-methylhept-6-en-2-yl]-9a-methyl-7-oxo-1h,2h,3h,3ah,3bh,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid

C29H40O4 (452.2926)

4,5-dihydroxy-6-methyl-2-({1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl}oxy)oxan-3-yl 2-methylbutanoate

C26H44O6 (452.3138)

(6r)-3-methyl-6-[(1s)-1-[(1s,3r,8r,11s,12s,15r,16r)-7,7,12,16-tetramethyl-6-oxopentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecan-15-yl]ethyl]-5,6-dihydropyran-2-one

C30H44O3 (452.329)

(1r,2s,5z,9r)-6-({[(1s,5r,9r)-10,10-dimethyl-2,6-dimethylidene-7-oxobicyclo[7.2.0]undecan-5-yl]oxy}methyl)-2,10,10-trimethylbicyclo[7.2.0]undec-5-en-4-one

C30H44O3 (452.329)

[5-(3-hydroxy-3-methylpent-4-en-1-yl)-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

2,4a,6a,9,9,12a,14a-heptamethyl-10-oxo-3,4,5,6,8,8a,11,12,14,14b-decahydro-1h-picene-2-carboxylic acid

C30H44O3 (452.329)

2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-6-methylhept-5-enoic acid

C30H44O3 (452.329)

(6e,10e)-6,10-dimethyl-12-(4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl acetate

C29H40O4 (452.2926)

(1r,2r,5s,6r,9r,14r,15r,19s,21r)-2,5,6,10,10,14,21-heptamethyl-23-oxahexacyclo[19.2.1.0²,¹⁹.0⁵,¹⁸.0⁶,¹⁵.0⁹,¹⁴]tetracos-17-ene-11,22-dione

C30H44O3 (452.329)

n-[3-(17-amino-1-hydroxy-1,5,9,14-tetraazaheptadecan-1-yl)propyl]-4-hydroxybenzamide

C23H44N6O3 (452.3475)

2,9,13,17,17-pentamethyl-7-(4-methylpent-3-en-1-yl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-6,16-dione

C30H44O3 (452.329)

2,6,11,15-tetramethyl-5,14-dipropyl-4,13,19,20-tetraoxatricyclo[14.2.1.1⁷,¹⁰]icosane-3,12-dione

C26H44O6 (452.3138)

1-(7-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,5,5a,7-tetrol

C27H48O5 (452.3502)

(5r)-5-[(2r)-2-[(1r,3ar,5ar,9ar,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]propyl]-3-methyl-5h-furan-2-one

C30H44O3 (452.329)

(6r)-6-[(1r,6s,9as,11ar)-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O4 (452.2926)

(3r,5s)-3-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-(2-methylprop-1-en-1-yl)oxolan-2-one

C30H44O3 (452.329)

(2z,6r)-6-[(4ar,6br,9r,10as,11bs)-4,4,6b,11b-tetramethyl-10-methylidene-3-oxo-1h,2h,4ah,5h,6h,7h,8h,9h,10ah,11h-cyclohexa[a]fluoren-9-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

(2e)-6-{4,4,6b,11b-tetramethyl-10-methylidene-3-oxo-1h,2h,4ah,5h,6h,6ah,7h,8h,9h,10ah-cyclohexa[a]fluoren-9-yl}-2-methylhept-2-enoic acid

C30H44O3 (452.329)

3,9-bis(2-methylpropyl)-6,12-bis(sec-butyl)-1,4,7,10-tetraazacyclododeca-1,4,7,10-tetraene-2,5,8,11-tetrol

C24H44N4O4 (452.3362)

5-(2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}propyl)-3-methyl-5h-furan-2-one

C30H44O3 (452.329)

(4as,6as,6br,8ar,12as,12br)-2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b-decahydro-1h-picene-4a-carboxylic acid

C30H44O3 (452.329)

(2r,6r,14r,19s,21s)-2,5,6,10,10,14,21-heptamethyl-23-oxahexacyclo[19.2.1.0²,¹⁹.0⁵,¹⁸.0⁶,¹⁵.0⁹,¹⁴]tetracos-17-ene-11,22-dione

C30H44O3 (452.329)

2α,3β-dihydroxy-28-norurs-12,17,19(20),21-te-traen-23-oiccid

C29H40O4 (452.2926)

{"Ingredient_id": "HBIN005224","Ingredient_name": "2\u03b1,3\u03b2-dihydroxy-28-norurs-12,17,19(20),21-te-traen-23-oiccid","Alias": "NA","Ingredient_formula": "C29H40O4","Ingredient_Smile": "CC1=C(C2=C(CCC3(C2=CCC4C3(CCC5C4(CC(C(C5(C)C(=O)O)O)O)C)C)C)C=C1)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15125","TCMID_id": "6054","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

3-oxo-11,13(18)-oleanadien-28-oicacid

C30H44O3 (452.329)

{"Ingredient_id": "HBIN009394","Ingredient_name": "3-oxo-11,13(18)-oleanadien-28-oicacid","Alias": "NA","Ingredient_formula": "C30H44O3","Ingredient_Smile": "CC1(CCC2(CCC3(C(=C2C1)C=CC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C)C(=O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "16389","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

5α-cyprinol

C27H48O5 (452.3502)

{"Ingredient_id": "HBIN011415","Ingredient_name": "5\u03b1-cyprinol","Alias": "NA","Ingredient_formula": "C27H48O5","Ingredient_Smile": "CC(CCCC(CO)CO)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "4581","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

5 beta-bufol sufate

C27H48O5 (452.3502)

{"Ingredient_id": "HBIN011461","Ingredient_name": "5 beta-bufol sufate","Alias": "NA","Ingredient_formula": "C27H48O5","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "30686","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

5β-bufol sulfate

C27H48O5 (452.3502)

{"Ingredient_id": "HBIN011462","Ingredient_name": "5\u03b2-bufol sulfate","Alias": "NA","Ingredient_formula": "C27H48O5","Ingredient_Smile": "CC(CCCC(C)(CO)O)C1CCC2C1(C(CC3C2C(CC4C3(CCC(C4)O)C)O)O)C","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2720","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

8α-hydroxyabda-13(16),14-dien-19-yl-(z)-4-hy-droxycinnamate

C29H40O4 (452.2926)

{"Ingredient_id": "HBIN013630","Ingredient_name": "8\u03b1-hydroxyabda-13(16),14-dien-19-yl-(z)-4-hy-droxycinnamate","Alias": "NA","Ingredient_formula": "C29H40O4","Ingredient_Smile": "CC1(CCCC2(C1CCC(C2CCC(=C)C=C)(C)O)C)COC(=O)C=CC3=CC=C(C=C3)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10299","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

ananosicacid c

C30H44O3 (452.329)

{"Ingredient_id": "HBIN015979","Ingredient_name": "ananosicacid c","Alias": "NA","Ingredient_formula": "C30H44O3","Ingredient_Smile": "CC(CCC=C(C)C(=O)O)C1CCC2(C1C(=C)CC3C2=CCC4C3(CCC(=O)C4(C)C)C)C","Ingredient_weight": "452.7 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1138","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "44559522","DrugBank_id": "NA"}

(1r,2r,3r,3as,3br,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,6s)-7-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-2,3,5,7-tetrol

C27H48O5 (452.3502)

(3s,6s,9s,12s)-3,9-bis[(2s)-butan-2-yl]-6,12-bis(2-methylpropyl)-1,4,7,10-tetraazacyclododeca-1,4,7,10-tetraene-2,5,8,11-tetrol

C24H44N4O4 (452.3362)

4,5,9,9,13-pentamethyl-19-(prop-1-en-2-yl)-21-oxahexacyclo[18.2.1.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tricosane-10,22-dione

C30H44O3 (452.329)

(2r,4as,6as,8ar,12as,14as,14br)-2,4a,6a,9,9,12a,14a-heptamethyl-10-oxo-3,4,5,6,8,8a,11,12,14,14b-decahydro-1h-picene-2-carboxylic acid

C30H44O3 (452.329)

(1r,2r,5s,8r,9r,10r,13s,14s,18s)-15-formyl-1,2,14,17,17-pentamethyl-8-(prop-1-en-2-yl)pentacyclo[11.7.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁸]icos-15-ene-5-carboxylic acid

C30H44O3 (452.329)

(1s,2r,5s,6r,9r,14r,15r,19s,21s)-2,5,6,10,10,14,21-heptamethyl-23-oxahexacyclo[19.2.1.0²,¹⁹.0⁵,¹⁸.0⁶,¹⁵.0⁹,¹⁴]tetracos-17-ene-11,22-dione

C30H44O3 (452.329)

2-{[1,4a-dimethyl-7-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl 2-methylbutanoate

C26H44O6 (452.3138)

(1r,3as,3bs,5r,5ar,7s,9r,9as,9bs,10r,11ar)-9a,11a-dimethyl-1-[(2r)-6-methylheptan-2-yl]-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7,9,10-pentol

C27H48O5 (452.3502)

methyl 2-[(4as,5r,8as)-2-[(2e)-3,7-dimethylocta-2,6-dien-1-yl]-6-methyl-5-(3-methylbut-2-en-1-yl)-1,4-dioxo-8,8a-dihydro-5h-naphthalen-4a-yl]acetate

C29H40O4 (452.2926)

(1s,4s,6r,7s)-7-[(1e)-2-[(1r,6s,7s,8s)-8-[(1r,2e)-1-hydroxy-2-methylbut-2-en-1-yl]-2,4,6,8-tetramethylbicyclo[4.2.0]octa-2,4-dien-7-yl]prop-1-en-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H40O4 (452.2926)

(1r,2r,3s,3as,3br,5s,5as,7s,9ar,9bs,11ar)-1-[(2r,6s)-7-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-2,3,5,7-tetrol

C27H48O5 (452.3502)

(6r)-6-[(1s)-1-[(1r,3as,3bs,9as,9bs,11as)-9a,9b,11a-trimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,10h,11h-cyclopenta[a]phenanthren-1-yl]ethyl]-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C29H40O4 (452.2926)

(1r,3s,3as,3br,5r,5ar,7s,9ar,9bs,11ar)-1-[(2r,6s)-7-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,5,5a,7-tetrol

C27H48O5 (452.3502)

(1r,3as,3br,4r,5ar,7s,9as,9bs,11s,11ar)-1-[(2s)-7-hydroxy-6-(hydroxymethyl)heptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-4,7,11-triol

C27H48O5 (452.3502)

1-[7-hydroxy-6-(hydroxymethyl)heptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-4,7,11-triol

C27H48O5 (452.3502)

(2e,6r)-6-[(1r,3s,3ar,5ar,9as,11ar)-3-hydroxy-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enal

C30H44O3 (452.329)

(1r,2r,3r,3as,3br,5r,5as,7s,9ar,9bs,11ar)-1-[(2r,6s)-7-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-2,3,5,7-tetrol

C27H48O5 (452.3502)

[(4ar,4bs,6ar,6bs,7r,11ar,13ar)-1,1,4a,6a,7,11a-hexamethyl-2,9-dioxo-3h,4h,4bh,5h,6h,6bh,7h,8h,11h,13h,13ah-indeno[2,1-a]phenanthren-10-yl]acetic acid

C29H40O4 (452.2926)

(2s,4as,6as,6br,8ar,12ar,12br)-1,2,6a,6b,9,9,12a-heptamethyl-10-oxo-2,3,4,5,6,7,8,8a,11,12,12b,13-dodecahydropicene-4a-carboxylic acid

C30H44O3 (452.329)

15-[1-(4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl)ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

C29H40O4 (452.2926)

3-(6,10-dimethylundeca-3,5,7,9-tetraen-2-ylidene)-7-hydroxy-6-(hydroxymethyl)-3a,6,9a-trimethyl-octahydrocyclopenta[a]naphthalen-2-one

C30H44O3 (452.329)

(4s,4ar,5s,7r,8r,8as)-2,5,8-trihydroxy-4-(3-hydroxypropanoyl)-4,7-dimethyl-3-[(2r)-undecan-2-yl]-4a,5,6,7,8,8a-hexahydronaphthalen-1-one

C26H44O6 (452.3138)

4,5,9,9,13,20,20-heptamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-10,23-dione

C30H44O3 (452.329)

6-{3a,6,6,9a,11a-pentamethyl-7,10-dioxo-1h,2h,3h,4h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enal

C30H44O3 (452.329)

7-{2-[8-(1-hydroxy-2-methylbut-2-en-1-yl)-2,4,6,8-tetramethylbicyclo[4.2.0]octa-2,4-dien-7-yl]prop-1-en-1-yl}-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H40O4 (452.2926)

(3-methylidene-2h-1-benzoxepin-7-yl)methyl (9z)-octadec-9-enoate

C30H44O3 (452.329)

2,4a,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,14b-decahydro-1h-picene-2-carboxylic acid

C30H44O3 (452.329)

(2e,6r)-6-[(1r,3ar,5ar,9ar,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

n-(20-amino-4,8,12,17-tetraazaicosan-1-yl)-2,5-dihydroxybenzenecarboximidic acid

C23H44N6O3 (452.3475)

3a,5a,8,8,11a-pentamethyl-9-oxo-1-(prop-1-en-2-yl)-1h,2h,3h,4h,5h,6h,7h,7ah,11bh,12h,13h,13ah,13bh-cyclopenta[a]chrysene-5b-carboxylic acid

C30H44O3 (452.329)

15-formyl-1,2,14,17,17-pentamethyl-8-(prop-1-en-2-yl)pentacyclo[11.7.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁸]icos-15-ene-5-carboxylic acid

C30H44O3 (452.329)

(5r)-5-[(2r)-2-[(1r,3ar,5as,9ar,9bs,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]propyl]-3-methyl-5h-furan-2-one

C30H44O3 (452.329)

(1r,3s,3as,3bs,5s,5as,7s,9as,9br,11ar)-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,7-tetrol

C27H48O5 (452.3502)

(1r,3r,3as,3bs,5s,5as,6r,7s,9as,9br,11ar)-1-[(2r,3e)-6-hydroxy-5-methylhex-3-en-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol

C26H44O6 (452.3138)

(2s,4as,6ar,6bs,8ar,12as,14br)-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,14b-decahydro-1h-picene-2-carboxylic acid

C30H44O3 (452.329)

(2z,6r)-6-[(3s,4ar,6br,9r,10as,11bs)-3-hydroxy-4,4,6b,11b-tetramethyl-10-methylidene-1h,2h,3h,4ah,5h,7h,8h,9h,10ah-cyclohexa[a]fluoren-9-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

6-(1-{9a,9b,11a-trimethyl-7-oxo-1h,2h,3h,3ah,3bh,4h,5h,10h,11h-cyclopenta[a]phenanthren-1-yl}ethyl)-3-(hydroxymethyl)-4-methyl-5,6-dihydropyran-2-one

C29H40O4 (452.2926)

(2z,6r)-6-[(3s,4ar,6br,11bs)-3-hydroxy-4,4,6b,11b-tetramethyl-10-methylidene-1h,2h,3h,4ah,5h,7h,8h,9h,10ah-cyclohexa[a]fluoren-9-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

(3e,3as,5ar,6s,7r,9ar,9bs)-3-[(3e,5e,7e)-6,10-dimethylundeca-3,5,7,9-tetraen-2-ylidene]-7-hydroxy-6-(hydroxymethyl)-3a,6,9a-trimethyl-octahydrocyclopenta[a]naphthalen-2-one

C30H44O3 (452.329)

6-[({10,10-dimethyl-2,6-dimethylidene-7-oxobicyclo[7.2.0]undecan-5-yl}oxy)methyl]-2,10,10-trimethylbicyclo[7.2.0]undec-5-en-4-one

C30H44O3 (452.329)

6-{3-hydroxy-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enal

C30H44O3 (452.329)

(2z,6r)-6-[(1r,3ar,5ar,9ar,9br)-3a,6,6,9a-tetramethyl-11-methylidene-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11ah-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

(1s,2s,4r,5s,10r,11s,14r,15r,18s)-15-[(1s)-1-[(2s)-4,5-dimethyl-6-oxo-2,3-dihydropyran-2-yl]ethyl]-5,10,14-trimethyl-3-oxapentacyclo[9.7.0.0²,⁴.0⁵,¹⁰.0¹⁴,¹⁸]octadec-7-en-9-one

C29H40O4 (452.2926)

(1r,3r,3as,3bs,5s,5as,7s,9as,9br,11ar)-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,7-tetrol

C27H48O5 (452.3502)

(2s,4s,7r,8s,9s,12r,13r,18r)-2,9,13,17,17-pentamethyl-7-(4-methylpent-3-en-1-yl)-5-oxapentacyclo[10.8.0.0²,⁹.0⁴,⁸.0¹³,¹⁸]icos-1(20)-ene-6,16-dione

C30H44O3 (452.329)

10,11-dihydroxy-2,4a,6a,9,12b,14a-hexamethyl-3,4,5,6,8,13,14,14b-octahydro-1h-picene-2-carboxylic acid

C29H40O4 (452.2926)

3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,7h,7ah,10h,11h,13h,13bh-cyclopenta[a]chrysene-6,9,12-trione

C30H44O3 (452.329)

(1r,3as,3br,9as,9bs,11as)-1-[(2r,5r)-5-ethyl-5-hydroxy-6-methylhept-6-en-2-yl]-9a-methyl-7-oxo-1h,2h,3h,3ah,3bh,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid

C29H40O4 (452.2926)

(3r,3ar,5as,7ar,11as,13as,13br)-3-isopropyl-3a,5a,8,8,11a,13a-hexamethyl-1h,2h,3h,4h,5h,7h,7ah,10h,11h,13h,13bh-cyclopenta[a]chrysene-6,9,12-trione

C30H44O3 (452.329)

(2e,6r)-6-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

3-(hydroxymethyl)-4,5-dimethoxycyclohex-2-en-1-yl octadec-3-enoate

C27H48O5 (452.3502)

(2r,3r,4s,4ar,6ar,6bs,14as,14br)-2,3-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,14,14a-decahydropicene-4-carboxylic acid

C29H40O4 (452.2926)

6-{3a,6,6,9a,11-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid

C30H44O3 (452.329)

(2s,3r,4s,5r,6r)-2-{[(1ar,4r,4as,7r,7as,7bs)-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl (2r)-2-methylbutanoate

C26H44O6 (452.3138)

(1r,3as,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-1-[(2r)-6-methylhept-5-en-2-yl]-1h,2h,3h,4h,5h,5ah,8h,9h-cyclopenta[a]phenanthrene-7,10,11-trione

C30H44O3 (452.329)

5-(2,5,8a-trimethyl-5-{[(3-phenylpropanoyl)oxy]methyl}-1,4,4a,6,7,8-hexahydronaphthalen-1-yl)-3-methylpent-2-enoic acid

C29H40O4 (452.2926)

(2s,3r,4s,5r,6r)-2-{[(1ar,4r,4as,7r,7as,7bs)-1,1,4,7-tetramethyl-octahydro-1ah-cyclopropa[e]azulen-4-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl 2-methylbutanoate

C26H44O6 (452.3138)

(3r,5r)-3-[(1r,3ar,5ar,7s,9as,11ar)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,7h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-5-(2-methylprop-1-en-1-yl)oxolan-2-one

C30H44O3 (452.329)

(2s,3r,4s,5r,6r)-2-{[(1s,4as,7r,8as)-1,4a-dimethyl-7-(prop-1-en-2-yl)-octahydronaphthalen-1-yl]oxy}-4,5-dihydroxy-6-methyloxan-3-yl (2s)-2-methylbutanoate

C26H44O6 (452.3138)

1-(6-hydroxy-5-methylhex-3-en-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol

C26H44O6 (452.3138)

(1r,3as,3br,9ar,9bs,11as)-1-[(2r,5r)-5-ethyl-5-hydroxy-6-methylhept-6-en-2-yl]-9a-methyl-7-oxo-1h,2h,3h,3ah,3bh,9bh,10h,11h-cyclopenta[a]phenanthrene-11a-carboxylic acid

C29H40O4 (452.2926)

(2z,6r)-6-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

[(1s,4s,5r,9s,10s,13r)-14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl 3-(4-hydroxyphenyl)propanoate

C29H40O4 (452.2926)

6-{3-hydroxy-4,4,6b,11b-tetramethyl-10-methylidene-1h,2h,3h,4ah,5h,7h,8h,9h,10ah-cyclohexa[a]fluoren-9-yl}-2-methylhept-2-enoic acid

C30H44O3 (452.329)

2,3-dihydroxy-4,6a,6b,11,12,14b-hexamethyl-1,2,3,4a,5,6,7,8,14,14a-decahydropicene-4-carboxylic acid

C29H40O4 (452.2926)

(1r,4s,5r,8r,13r,14s,17r,18r)-4,5,9,9,13,20,20-heptamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-10,23-dione

C30H44O3 (452.329)

(2s,3r,4r,5r,6s)-2-{[(3r)-5-[(1s,4as,8as)-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy}-6-(hydroxymethyl)oxane-3,4,5-triol

C26H44O6 (452.3138)

(2s,4as,6as,6br,8ar,12ar,12br,14br)-2,4a,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,12b,13,14b-decahydro-1h-picene-2-carboxylic acid

C30H44O3 (452.329)

[(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

{14-formyl-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl}methyl 3-(4-hydroxyphenyl)propanoate

C29H40O4 (452.2926)

(2e,6r)-6-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

7,7,12,16-tetramethyl-15-(6-methyl-4-oxohept-5-en-2-yl)pentacyclo[9.7.0.0¹,³.0³,⁸.0¹²,¹⁶]octadecane-6,14-dione

C30H44O3 (452.329)

(1r,3r,3as,3bs,5s,5as,6r,7s,9as,9br,11ar)-1-[(2r,3e,5r)-6-hydroxy-5-methylhex-3-en-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,6,7-pentol

C26H44O6 (452.3138)

9a,11a-dimethyl-1-(6-methylheptan-2-yl)-tetradecahydrocyclopenta[a]phenanthrene-5,5a,7,9,10-pentol

C27H48O5 (452.3502)

1-(7-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthrene-2,3,5,7-tetrol

C27H48O5 (452.3502)

(1s,4s,5r,8r,13s,14r,17s,18r)-4,5,9,9,13,20,20-heptamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-10,23-dione

C30H44O3 (452.329)

6-{3a,6,6,9a-tetramethyl-11-methylidene-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11ah-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enoic acid

C30H44O3 (452.329)

6-{3a,6,6,9a,11a-pentamethyl-4,7-dioxo-1h,2h,3h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-2-methylhept-2-enal

C30H44O3 (452.329)

(2r,6r)-6-[(1r,5as,6s,9as,11ar)-6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methyl-3-methylideneheptanoic acid

C29H40O4 (452.2926)

2,2,6a,6b,9,9,12a-heptamethyl-10-oxo-3,4,5,6,7,8,8a,11,12,12b-decahydro-1h-picene-4a-carboxylic acid

C30H44O3 (452.329)

2-{7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl}-1-(4-methylfuran-2-yl)propan-1-one

C30H44O3 (452.329)

(1s,4s,5r,8r,13s,14r,17s,18r,19s,20r)-4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-10,23-dione

C30H44O3 (452.329)

(1s,4s,6r,7s)-7-[(1e)-2-[(1s,6r,7r,8r)-8-[(1r,2e)-1-hydroxy-2-methylbut-2-en-1-yl]-2,4,6,8-tetramethylbicyclo[4.2.0]octa-2,4-dien-7-yl]prop-1-en-1-yl]-4,6,7-trimethyl-2-oxabicyclo[2.2.1]heptane-3,5-dione

C29H40O4 (452.2926)

(2s,3r,4r,5r,6s)-2-{[(3r)-5-[(1s,4ar,6s,8ar)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl]-3-methylpent-1-en-3-yl]oxy}-6-methyloxane-3,4,5-triol

C26H44O6 (452.3138)

2-[(1s,3as,7s,9as,11as)-7-hydroxy-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,4h,5h,5ah,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-1-(4-methylfuran-2-yl)propan-1-one

C30H44O3 (452.329)

[6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methyl 3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

(2z,6e,10e)-6,10-dimethyl-12-(4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl acetate

C29H40O4 (452.2926)

(2z,6r)-6-[(3s,4ar,6br,9r,10ar,11bs)-3-hydroxy-4,4,6b,11b-tetramethyl-10-methylidene-1h,2h,3h,4ah,5h,7h,8h,9h,10ah-cyclohexa[a]fluoren-9-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

1-(5-hydroxy-6-methylheptan-2-yl)-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,7-tetrol

C27H48O5 (452.3502)

(1r,3ar,5ar,9as,11ar)-1-[(2s,5e)-7-hydroxy-6-methyl-3-oxohept-5-en-2-yl]-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-7-one

C30H44O3 (452.329)

(1r,2r,5s,8r,14s,18s)-15-formyl-1,2,14,17,17-pentamethyl-8-(prop-1-en-2-yl)pentacyclo[11.7.0.0²,¹⁰.0⁵,⁹.0¹⁴,¹⁸]icos-15-ene-5-carboxylic acid

C30H44O3 (452.329)

[(1s,4ar,5s,8ar)-5-[(3r)-3-hydroxy-3-methylpent-4-en-1-yl]-1,4a-dimethyl-6-methylidene-hexahydro-2h-naphthalen-1-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

2-[3-(furan-3-yl)propylidene]-8,12,16-trimethyl-5-(prop-1-en-2-yl)heptadeca-7,11,15-trienoic acid

C30H44O3 (452.329)

methyl 2-[2-(3,7-dimethylocta-2,6-dien-1-yl)-6-methyl-5-(3-methylbut-2-en-1-yl)-1,4-dioxo-8,8a-dihydro-5h-naphthalen-4a-yl]acetate

C29H40O4 (452.2926)

(2s,5r,6r,10r,13r,14r)-2,5,10,14-tetramethyl-13-[(2s)-1-(4-methylfuran-2-yl)-1-oxopropan-2-yl]tetracyclo[7.7.0.0²,⁶.0¹⁰,¹⁴]hexadec-1(9)-ene-5-carboxylic acid

C29H40O4 (452.2926)

(2r)-2-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-6-methylhept-5-enoic acid

C30H44O3 (452.329)

(2z,6r)-6-[(1r,3ar,5ar,9ar,9br,11as)-3a,6,6,9a-tetramethyl-11-methylidene-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11ah-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

4,5,9,9,13,19,20-heptamethyl-24-oxahexacyclo[15.5.2.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-15-ene-10,23-dione

C30H44O3 (452.329)

6,10-dimethyl-12-(4-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trien-1-yl acetate

C29H40O4 (452.2926)

(1r,4as,7as)-3-[(2e)-4-(2,5-dimethoxy-3-methylphenyl)-2-methylbut-2-en-1-yl]-4a,5',5',7a-tetramethyl-6,7-dihydro-5h-spiro[cyclopenta[c]pyran-1,2'-furan]

C29H40O4 (452.2926)

6-{6,9a,11a-trimethyl-7,10-dioxo-1h,2h,4h,5h,5ah,6h,8h,9h,11h-cyclopenta[a]phenanthren-1-yl}-2-methyl-3-methylideneheptanoic acid

C29H40O4 (452.2926)

[(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methyl (2e)-3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

(2z,6r)-6-[(3as,5ar,9as,11r)-3a,6,6,9a,11-pentamethyl-7-oxo-2h,3h,4h,5h,5ah,8h,9h,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

1-(7-hydroxy-6-methyl-3-oxohept-5-en-2-yl)-3a,6,6,9a,11a-pentamethyl-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-7-one

C30H44O3 (452.329)

[(1s,4s,5r,9s,10r,13r,14r)-14-formyl-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadecan-5-yl]methyl 3-(4-hydroxyphenyl)propanoate

C29H40O4 (452.2926)

(1r,2r,5r,10r,11r,14r,15s,16r,20r,22s)-1,2,6,6,10,22-hexamethyl-17-methylidene-19-oxahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²².0¹⁶,²⁰]tetracosane-7,18-dione

C30H44O3 (452.329)

(2e,6r)-6-[(7r,10r,11s,13as,13br)-4,4,7,11,13b-pentamethyl-3-oxo-7h,8h,9h,10h,11h,12h,13h,13ah-cyclonona[a]naphthalen-10-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

(6r)-6-[(4ar,6as,6bs,10ar,11bs)-4,4,6b,10,11b-pentamethyl-3-oxo-1h,2h,4ah,5h,6h,6ah,7h,8h,10ah-cyclohexa[a]fluoren-9-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

2-{[5-(6-hydroxy-5,5,8a-trimethyl-2-methylidene-hexahydro-1h-naphthalen-1-yl)-3-methylpent-1-en-3-yl]oxy}-6-methyloxane-3,4,5-triol

C26H44O6 (452.3138)

2-{3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl}-6-methyl-4-oxohept-5-enal

C30H44O3 (452.329)

(1s,4r,5r)-3-(hydroxymethyl)-4,5-dimethoxycyclohex-2-en-1-yl (3e)-octadec-3-enoate

C27H48O5 (452.3502)

[14-(hydroxymethyl)-5,9-dimethyltetracyclo[11.2.1.0¹,¹⁰.0⁴,⁹]hexadec-14-en-5-yl]methyl 3-(4-hydroxyphenyl)propanoate

C29H40O4 (452.2926)

6-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

(1r,2s,5s,6r,7s,10r,11s,14s,15r,16s)-2,6,11,15-tetramethyl-5,14-dipropyl-4,13,19,20-tetraoxatricyclo[14.2.1.1⁷,¹⁰]icosane-3,12-dione

C26H44O6 (452.3138)

(2e,6r)-6-[(1s,3as,5ar,9as,11as)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,4h,5h,5ah,10h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

ethyl (2r,4r)-4-[(1r,3as,3br,4r,5as,7r,9as,9bs,11s,11ar)-4,7,11-trihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-hydroxypentanoate

C26H44O6 (452.3138)

ethyl 2-hydroxy-4-{4,7,11-trihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl}pentanoate

C26H44O6 (452.3138)

(2e,6s)-6-[(1r,3ar,5ar,9as,11ar)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,11h-cyclopenta[a]phenanthren-1-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

(3-methylidene-2h-1-benzoxepin-7-yl)methyl octadec-9-enoate

C30H44O3 (452.329)

(3z,3as,5ar,6s,7r,9ar,9bs)-3-[(3e,5e,7e)-6,10-dimethylundeca-3,5,7,9-tetraen-2-ylidene]-7-hydroxy-6-(hydroxymethyl)-3a,6,9a-trimethyl-octahydrocyclopenta[a]naphthalen-2-one

C30H44O3 (452.329)

(3s,5s)-3-[(1s,3as,5ar,9ar,9br,11as)-3a,6,6,9a,11a-pentamethyl-7-oxo-1h,2h,3h,5h,5ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-1-yl]-5-(2-methylprop-1-en-1-yl)oxolan-2-one

C30H44O3 (452.329)

(2z,6r)-6-[(4ar,6as,6bs,10ar,11bs)-4,4,6b,10,11b-pentamethyl-3-oxo-1h,2h,4ah,5h,6h,6ah,7h,8h,10ah-cyclohexa[a]fluoren-9-yl]-2-methylhept-2-enoic acid

C30H44O3 (452.329)

[(1s,4as,5r,6r,8ar)-6-hydroxy-1,4a,6-trimethyl-5-(3-methylidenepent-4-en-1-yl)-hexahydro-2h-naphthalen-1-yl]methyl (2z)-3-(4-hydroxyphenyl)prop-2-enoate

C29H40O4 (452.2926)

(1r,3s,3as,3bs,5r,5as,7s,9as,9br,11ar)-1-[(2r,5s)-5-hydroxy-6-methylheptan-2-yl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthrene-3,3b,5,7-tetrol

C27H48O5 (452.3502)